FIGURE 5.
Effect of milk extracellular vesicle treatment in the OPG/RANKL axis in serum and femur. Serum levels of (A) osteoprotegerin (OPG), (B) receptor activator of nuclear factor κB ligand (RANKL), and (C) RANKL/OPG ratio. (D) mRNA expression of Rankl/Opg ratio in the femur. Analyses were performed in mice (i) pseudo-operated (SHAM) or (ii) ovariectomized (OVX), (iii) non-treated (control), or (iv) treated with milk extracellular vesicles (mEVs). Values are means ± SEM of 6–8 animals per group. * vs. respective SHAM group and # vs. non-treated group.